Study on the rule and mechanism of treating functional gastrointestinal diseases from the perspective of liver and splee
- Conditions
- Functional gastroenteropathy
- Registration Number
- ITMCTR2000003417
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Healthy volunteers without abnormal clinical manifestations;
2. Patients who meet nerd's syndrome of disharmony of liver and stomach and IBS-D syndrome of liver depression and spleen deficiency;
3. Patients between 18-70 years old;
4. Probiotics such as antibiotics, steroids, Chinese herbal medicine preparations (including oral and intravenous), microecological preparations or yoghurt, etc. taken in the past week;
5. The subjects were informed and signed the informed consent voluntarily;
6. Patients with certain reading ability.
1. Patients with serious heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases;
2. Patients with other organic diseases of the digestive system (such as peptic ulcer) or systemic diseases (such as hyperthyroidism and diabetes) that affect the gastrointestinal motility;
3. Patients who are using or need to use drugs that may affect gastrointestinal function (antidiarrheal, antidepressant, antianxiety, intestinal flora regulator, antibiotics, etc.);
4. Patients who have a history of drug allergy and a history of severe food allergy;
5. Patients with metal medical devices implanted in the body;
6. Patients with pregnancy plan within three months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IBS - SSS scale;7 point Likert scale;
- Secondary Outcome Measures
Name Time Method Hamilton anxiety scale;IBS - QOL scale;Overall Impression scale;TCM Syndrome Score Scale;Hamilton depression scale;Symptoms integral scale;SF - 36 scale;